Enhabit (EHAB) Stock Analysis & Winston Score
Enhabit, Inc. provides home health and hospice care services across the United States. The company sends nurses and therapists directly to patients' homes to help them recover from surgeries, manage chronic illnesses, or receive end-of-life care. It is one of the larger independent home health and hospice providers in the country, serving Medicare and Medicaid patients as its primary customer base. Enhabit earns most of its revenue through reimbursements from government payers, mainly Medicare, which sets the rates it receives for each episode of care. The company operates hundreds of locations across roughly 30 states, giving it a broad geographic footprint compared to smaller regional competitors. Its main challenge is thin profitability — the negative return on invested capital signals the business is not yet earning back what it spends — and ongoing pressure from Medicare reimbursement rate changes could further squeeze margins in the near term.
Winston Score: 39/100 — Below Average
Below-average fundamentals — multiple weak pillars.
- Quality: Mixed (11/30)
- Growth: Mixed (9/20)
- Cash Flow: Weak (2/10)
- Stability: Good (5/10)
- Valuation: Data not available (0/10)
- Ownership: Good (10/15)
Key Facts
Price: $13.80
Market Cap: $707M
Sector: Healthcare
Industry: Medical - Care Facilities

